We biochemically measured the amounts of key tight junction proteins, CLDN5 and OCLN, in the temporal cortex of a large post mortem brain cohort (N = 469) of neuropathologically confirmed AD cases. This evidence concerns the gene CLDN5 and Alzheimer disease.